„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in Paris.
Please meet our CEO Eva Kovacova in Paris to discuss future of non-invasive cancer diagnostics based on analysis of glycans.”
